149
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Alternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma

, , , , &
Pages 797-800 | Received 04 Apr 2014, Accepted 24 May 2014, Published online: 17 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, Masahiko Sugitani, Yusuke Amano, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Hitomi Kodaira, Noriyoshi Iriyama, Sumiko Kobayashi, Atsuko Hojo, Yujin Kobayashi, Yukio Hirabayashi, Machiko Kusuda, Yoshihiro Hatta, Tomohiro Nakayama & Masami Takei. (2016) Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy. Leukemia & Lymphoma 57:12, pages 2784-2790.
Read now
Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Asami Izu, Masahiko Sugitani, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Atsuko Hojo, Hitomi Kodaira, Mai Yagi, Yujin Kobayashi, Noriyoshi Iriyama, Sumiko Kobayashi, Satomi Kiso, Yukio Hirabayashi, Yoshihiro Hatta & Masami Takei. (2016) Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy. Leukemia & Lymphoma 57:6, pages 1335-1341.
Read now

Articles from other publishers (1)

Shaoying Li, Annapurna Saksena, Parth Desai, Jie Xu, Zhuang Zuo, Pei Lin, Guilin Tang, C. Cameron Yin, Adam Seegmiller, Jeffrey L. Jorgensen, Roberto N. Miranda, Nishitha M Reddy, Carlos Bueso-Ramos & L. Jeffrey Medeiros. (2016) Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma . Oncotarget 7:25, pages 38122-38132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.